SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-010144
Filing Date
2020-04-03
Accepted
2020-04-03 16:56:24
Documents
2
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7601
2 EX-24 DOCUMENT attachment1.htm EX-24 3542
  Complete submission text file 0000899243-20-010144.txt   14429
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address
Stampacchia Otello (Reporting) CIK: 0001361712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 20774257

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV, L.P. (Reporting) CIK: 0001528382 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 20774254

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV GP, L.P. (Reporting) CIK: 0001528383 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 20774255

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV G.P. Manager, Ltd. (Reporting) CIK: 0001624456 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 20774256

Mailing Address C/O OMEGA FUND MANAGEMENT, LLC 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address
Paster Anne-Mari (Reporting) CIK: 0001652863 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 20774258

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Issuer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences